Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.

<h4>Background</h4>In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug levels pointed to widespread product nonuse, despite high adherence estimated by self-reports and clinic product counts. Using a socio-ecological framework (SEF), we explored socio-cultural an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ariane van der Straten, Jonathan Stadler, Elizabeth Montgomery, Miriam Hartmann, Busiswe Magazi, Florence Mathebula, Katie Schwartz, Nicole Laborde, Lydia Soto-Torres
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7f9d62bd8e37460ab473ebb3b54a3246
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7f9d62bd8e37460ab473ebb3b54a3246
record_format dspace
spelling oai:doaj.org-article:7f9d62bd8e37460ab473ebb3b54a32462021-11-18T08:31:34ZWomen's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.1932-620310.1371/journal.pone.0089118https://doaj.org/article/7f9d62bd8e37460ab473ebb3b54a32462014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586534/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug levels pointed to widespread product nonuse, despite high adherence estimated by self-reports and clinic product counts. Using a socio-ecological framework (SEF), we explored socio-cultural and contextual factors that influenced participants' experience of daily vaginal gel and oral tablet regimens in VOICE.<h4>Methods</h4>In Johannesburg, a qualitative ancillary study was concurrently conducted among randomly selected VOICE participants assigned to in-depth interviews (n = 41), serial ethnographic interviews (n = 21), or focus group discussions (n = 40). Audiotaped interviews were transcribed, translated, and coded thematically for analysis.<h4>Results</h4>Of the 102 participants, the mean age was 27 years, and 96% had a primary sex partner with whom 43% cohabitated. Few women reported lasting nonuse, which they typically attributed to missed visits, lack of product replenishments, and family-related travel or work. Women acknowledged occasionally skipping or mistiming doses because they forgot, were busy, felt lazy or bored, feared or experienced side effects. However, nearly all knew or heard of other study participants who did not use products daily. Three overarching themes emerged from further analyses: ambivalence toward research, preserving a healthy status, and managing social relationships. These themes highlighted the profound and complex meanings associated with participating in a blinded HIV PrEP trial and taking antiretroviral-based products. The unknown efficacy of products, their connection with HIV infection, challenges with daily regimen given social risks, lack of support-from partners and significant others-and the relationship tradeoffs entailed by using the products appear to discourage adequate product use.<h4>Conclusions</h4>Personal acknowledgment of product nonuse was challenging. This qualitative inquiry highlighted key influences at all SEF levels that shaped women's perceptions of trial participation and experiences with investigational products. Whether these impacted women's behaviors and may have contributed to ineffective trial results warrants further investigation.Ariane van der StratenJonathan StadlerElizabeth MontgomeryMiriam HartmannBusiswe MagaziFlorence MathebulaKatie SchwartzNicole LabordeLydia Soto-TorresPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 2, p e89118 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ariane van der Straten
Jonathan Stadler
Elizabeth Montgomery
Miriam Hartmann
Busiswe Magazi
Florence Mathebula
Katie Schwartz
Nicole Laborde
Lydia Soto-Torres
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
description <h4>Background</h4>In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug levels pointed to widespread product nonuse, despite high adherence estimated by self-reports and clinic product counts. Using a socio-ecological framework (SEF), we explored socio-cultural and contextual factors that influenced participants' experience of daily vaginal gel and oral tablet regimens in VOICE.<h4>Methods</h4>In Johannesburg, a qualitative ancillary study was concurrently conducted among randomly selected VOICE participants assigned to in-depth interviews (n = 41), serial ethnographic interviews (n = 21), or focus group discussions (n = 40). Audiotaped interviews were transcribed, translated, and coded thematically for analysis.<h4>Results</h4>Of the 102 participants, the mean age was 27 years, and 96% had a primary sex partner with whom 43% cohabitated. Few women reported lasting nonuse, which they typically attributed to missed visits, lack of product replenishments, and family-related travel or work. Women acknowledged occasionally skipping or mistiming doses because they forgot, were busy, felt lazy or bored, feared or experienced side effects. However, nearly all knew or heard of other study participants who did not use products daily. Three overarching themes emerged from further analyses: ambivalence toward research, preserving a healthy status, and managing social relationships. These themes highlighted the profound and complex meanings associated with participating in a blinded HIV PrEP trial and taking antiretroviral-based products. The unknown efficacy of products, their connection with HIV infection, challenges with daily regimen given social risks, lack of support-from partners and significant others-and the relationship tradeoffs entailed by using the products appear to discourage adequate product use.<h4>Conclusions</h4>Personal acknowledgment of product nonuse was challenging. This qualitative inquiry highlighted key influences at all SEF levels that shaped women's perceptions of trial participation and experiences with investigational products. Whether these impacted women's behaviors and may have contributed to ineffective trial results warrants further investigation.
format article
author Ariane van der Straten
Jonathan Stadler
Elizabeth Montgomery
Miriam Hartmann
Busiswe Magazi
Florence Mathebula
Katie Schwartz
Nicole Laborde
Lydia Soto-Torres
author_facet Ariane van der Straten
Jonathan Stadler
Elizabeth Montgomery
Miriam Hartmann
Busiswe Magazi
Florence Mathebula
Katie Schwartz
Nicole Laborde
Lydia Soto-Torres
author_sort Ariane van der Straten
title Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
title_short Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
title_full Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
title_fullStr Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
title_full_unstemmed Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
title_sort women's experiences with oral and vaginal pre-exposure prophylaxis: the voice-c qualitative study in johannesburg, south africa.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/7f9d62bd8e37460ab473ebb3b54a3246
work_keys_str_mv AT arianevanderstraten womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
AT jonathanstadler womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
AT elizabethmontgomery womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
AT miriamhartmann womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
AT busiswemagazi womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
AT florencemathebula womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
AT katieschwartz womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
AT nicolelaborde womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
AT lydiasototorres womensexperienceswithoralandvaginalpreexposureprophylaxisthevoicecqualitativestudyinjohannesburgsouthafrica
_version_ 1718421692223586304